The involvement of GABA-transaminase in the blood-brain barrier to radiolabelled GABA
- PMID: 6475496
- DOI: 10.1007/BF00695607
The involvement of GABA-transaminase in the blood-brain barrier to radiolabelled GABA
Abstract
The involvement of GABA-transaminase (GABA-T) in the blood-brain barrier to GABA was investigated using a sensitive radiotracer technique which allows measurement of tracer permeation as a cerebrovascular permeability-area product, PA. In Sprague-Dawley rats subjected to peripheral GABA-T inhibition and occlusion of hepatic circulation, chromatographic (TLC) analysis together with lyophylized plasma samples showed the radioactivity measured in brain parenchyma was derived from the permeation of unchanged [3H]GABA and not its blood-borne metabolites. Permeation (PA) of i.v. injected [3H]GABA was poor in all brain regions examined. Pretreatment of these rats with various compounds known to inhibit endothelial GABA-T activity did not cause any increased permeation of [3H]GABA into the brain. These results suggest that the poor permeation of GABA into the rat brain is unrelated to the activity of GABA-T at endothelial sites.
Similar articles
-
Cerebral endothelial GABA-T activity: effects of in vivo GABA-T inhibition.Neurosci Lett. 1986 Jun 6;67(1):48-52. doi: 10.1016/0304-3940(86)90206-5. Neurosci Lett. 1986. PMID: 3725199
-
Use of inhibitors of gamma-aminobutyric acid (GABA) transaminase for the estimation of GABA turnover in various brain regions of rats: a reevaluation of aminooxyacetic acid.J Neurochem. 1989 Dec;53(6):1737-50. doi: 10.1111/j.1471-4159.1989.tb09239.x. J Neurochem. 1989. PMID: 2809589
-
Regional brain GABA metabolism and release during hepatic coma produced in rats chronically treated with carbon tetrachloride.Neurochem Res. 1988 Jan;13(1):37-44. doi: 10.1007/BF00971852. Neurochem Res. 1988. PMID: 3368028
-
Basic aspects of GABA-transaminase in neuropsychiatric disorders.Clin Biochem. 1995 Apr;28(2):145-54. doi: 10.1016/0009-9120(94)00074-6. Clin Biochem. 1995. PMID: 7628073 Review.
-
Is hepatic GABA transaminase a promising target for obesity and epilepsy treatments?Biosci Biotechnol Biochem. 2024 Jul 22;88(8):839-849. doi: 10.1093/bbb/zbae066. Biosci Biotechnol Biochem. 2024. PMID: 38749549 Review.
Cited by
-
United States Pharmacopeia (USP) Safety Review of Gamma-Aminobutyric Acid (GABA).Nutrients. 2021 Aug 10;13(8):2742. doi: 10.3390/nu13082742. Nutrients. 2021. PMID: 34444905 Free PMC article. Review.
-
Augmentation of cysteamine-induced ulceration of rat duodenum by systemically administered gamma-aminobutyric acid (GABA).Dig Dis Sci. 1989 Aug;34(8):1211-6. doi: 10.1007/BF01537269. Dig Dis Sci. 1989. PMID: 2546721
References
MeSH terms
Substances
LinkOut - more resources
Miscellaneous